Deficient habituation of evoked cortical potentials in migraine: A link between brain biology, behavior and trigeminovascular activation?

Biomedicine and Pharmacotherapy

Volumn 50, Issue 2, 1996, Pages 71-78

  Schoenen, J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Augmenting; Cortical evoked potentials; Habituation; Migraine; Pathophysiology; Reducing; Serotonin

Indexed keywords

SEROTONIN;

BEHAVIOR; BRAIN STEM; EVOKED CORTICAL RESPONSE; HEMOSTASIS; HUMAN; MIGRAINE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TRIGEMINAL NERVE;

EID: 0029968131     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/0753-3322(96)84716-0     Document Type: Article

References (78)

1. Amery WK. Brain hypoxia: the turning-point in the genesis of the migraine attack? Cephalalgia 1982;2:83-109
2. Anthony M, Lance JW. Serotonin in Migraine. In: Pearce JMS, ed. Topics in Migraine. London: Heinemann, 1975
3. 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 1992;42:1209-14
4. Barkley GL, Tepley N, Simkins R, Moran J, Welch KMA. Neuromagnetic fields in migraine: preliminary findings. Cephalalgia 1990;10:171-6
5. Besken E, Pothmann R, Sartory C. Contingent negative variation in childhood migraine. Cephalalgia 1993;13:42-3
6. Blau JN. Adult migraine: the patient observed. In: Blau JN, ed. Migraine, Clinical, Therapeutic, Conceptual and Research Aspects. London: Chapman & Hall, 1987;3-30
7. Buchsbaum MS, Silverman J. Stimulus intensity control and the cortical evoked response. Psychosom Med 1968; 30:12-22
8. Connolly JF, Gaxel M, Clifford Rose F. Migraine patients exhibit abnormalities in the visual evoked potential. J Neurol Neurosurg Psychiatr 1982;45:464-7
9. D'Andrea G, Welch KMA, Riddle JM, Grunfeld S. Platelet serotonin metabolism and ultrastructure in migraine. Arch Neurol 1989;46:1187-9
10. D'Andrea G, Cananzi AR, Joseph R et al. Platelet glycine, glutmate and aspartate in primary headache. Cephalalgia 1991;11:197-200
11. Diener HC, Ndosi NK, Koletzki E, Langohr HD. Visual evoked potentials in migraine. In: Pfaffenrath V, Lundberg PJ, Sjaastad O eds. Updating in headache. Berlin: Springer Verlag, 1984;439-65
12. Diener HC, Scholz E, Dichgans J, Gerber WD. Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials. Ann Neurol 1989;25:125-30
13. Edmeads J. Migraine - Disease or syndrome? Path Biol 1992;40:279-83
14. Ferrari MD. Biochemistry of migraine. Path Biol 1992; 40:284-92
15. Ferrari MD, Saxena PR. On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 1993;13: 151-65
16. Ferrari MD, Odink J, Tapparelli C, Van Kempen GMJ, Pennings EJM, Bruyn GW. Serotonin metabolism in migraine. Neurology 1989;39:1239-42
17. Ferrari MD, Odink J, Bos KD, Malessy MJA, Bruyn GW. Neuroexcitatory plasma amino acids are elevated in migraine. Neurology 1990;40:1582-6
18. Fox PT, Raichle ME, Mintum MA, Dence C. Nonoxidative glucose consumption during focal physiological neural activity. Science 1988;241:462-4
19. Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral artery dilation reversal by sumatriptan. Lancet 1991;338:13-17
20. Gawel M, Connolly JF, Clifford Rose FC. Migraine patients exhibit abnormalities in the visual evoked potential. Headache 1983;23:49-52
21. Gerber WD, Schoenen J. Migraine etiopathogenesis - new sites. "Born to be wild". 3rd Congress on headache in Childhood and Adolescence, Budapest, May 4-6, 1995;15
22. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48-56
23. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990;28:183-7
24. Grossberg S, Gutowski WE. Neural dynamics of decision making under rist: an effective balance and cognitive-emotional interactions. Psychol Rev 1987;94:300-18
25. Hardebo JE. A cortical excitatory wave may cause both the aura and the headache of migraine. Cephalalgia 1992;12:75-80
26. Hay KM, Mortimer MJ, Barker DC, Debney LM, Good PA. 1044 Women with migraine: the effect of environmental stimuli. Headache 1994;34:166-8
27. Hegerl U, Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiat 1993;33: 173-87
28. Humphrey PPA. 5-Hydroxytryptamine and the pathophysiology of migraine. J Neurol 1991;238:S38-S44
29. Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol Rev 1992;72:165-229
30. Joutel A, Bousser MG, Biousse V et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 1993;5:40-5
31. Kandel ER. Cellular mechanisms of learning and biological basis of individuality. In: Kandel ER, Schwartz JH, Jessell TM eds. Principles of Neurol Science. New York: Elsevier, 1992;1009-31
32. Kandel ER, Abrams T, Bernier L, Carew TJ, Hawkins RD, Schwartz JH. Classical conditioning and sensitization show aspects of the same molecular cascade in Aplysi. Cold Spring Harbor Symp. Quarnt Biol 1983;48:821-30
33. Kennard C, Gawel M, Rudolf N, Clifford Rose F. Visual evoked potentials in migraine subjects. Res Clin Studies Headache 1978;6:73-80
34. Knott JR, Irwin DA. Anxiety, stress and the contingent negative variation. Arch Gen Psychiatry 1973;29:538-41
35. Kropp P, Gerber WD. Is increased amplitude of contingent negative variation in migraine due to cortical hyperactivity or to reduced habituation? Cephalalgia 1993;13:37-41
36. Kropp P, Gerber WD. Contingent negative variation during migraine attack and interval: evidence for normalization of slow cortical potentials during the attack. Cephalalgia 1995;15:123-8
37. Lance JW. Headache. Ann Neurology 1981;10:1-10
38. Lance JW. Mechanisms and Management of Headache. 5th edition, Oxford: Butterworth & Heinemann, 1993
39. Lauritzen M, Skyhøj Olsen T, Lassen NA, Paulson OB. The changes of regional cerebral blood flow during the course of classical migraine attacks. Ann Neurol 1983a;13: 633-41
40. Lauritzen M, Skyhøj Olsen T, Lassen NA, Paulson OB. Regulation of regional cerebral blood flow during and between migraine attacks. Ann Neurol 1983b;14:569-72
41. Leão AA. Spreading depression of activity in cerebral cortex. J Neurophysiol 1944;7:359-90
42. Lehtonen JB. Visual evoked potentials for single flashes and flickering light in migraine. Headache 1974;14:1-12
43. Lehtonen JB, Hyyppä MT, Kaihola HL, Kangasniemi P, Lang AH. Visual evoked potentials in menstrual migraine. Headache 1979;19:63-70
44. Lukas JH, Siegel J. Cortical mechanisms that augment or reduce evoked potentials in cats. Science 1977;198:73-75
45. Maertens de Noordhout A, Timsit-Berthier M, Timsit M, Schoenen J. Contingent negative variation in headache. Ann Neurol 1986;19:78-90
46. Mesulam MM. Large-scale neurocognitive networks and distributed processing for attention language and memory. Ann Neurol 1990;28:597-613
47. Milner PM. Note on a possible correspondence between the scotomas of migraine and spreading depression of Leão. EEG Clin Neurophysiol 1958;10:705
48. Monnier M, Boehmer A, Scholer A. Early habituation, dishabituation and generalization induced in the visual centers by colour stimuli. Vision Res 1976;16:1479-504
49. Montagna P, Sayuegna T, Cortelli P, Lugaresi E. Migraine as a defect of brain oxidative metabolism: a hypothesis. J Neurol 1989;236:124-5
50. 31P-Magnetic resonance spectroscopy in migraine without aura. Neurology 1994;44:666-8
51. Moskowitz MA. The visceral organ brain: implications for the pathophysiology of vascular head pain. Neurology 1991;41:182-6
52. Moskowitz MA. Neurovascular mechanisms in the pathogenesis and treatment of migraine. Abstacts 7th World Congress on Pain. Seattle: IASP Publications, 1993;253
53. Moskowitz MA, Cutrer FM. Sumatriptan: a Receptor-Targeted Treatment of Migraine. Ann Rev Med 1993;44:145-54
54. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981;9:344-52
55. Olesen J, Iversen HK, Thomsen LL. Nitric oxide supersensitivity. A possible molecular mechnism of migraine pain. Neuroreport 1993;4:1027-30
56. Phelps ME, Kuhl DE. Metabolic mapping of the brain's response to visual stimulation: studies in humans. Science 1981;211:1445-8
57. 1H NMR in human visual cortex during physiologic stimulation. Proc Nat Acad Sci USA 1991;88:5829-31
58. Ramadan NM, Halvorsen H, Vande-Linde A, Levine SR, Helpern JA, Welch KMA. Low brain magnesium in migraine. Headache 1989;29:590-3
59. Sangiorgi S, Mochi M, Riva R, Cortelli P, Monari L, Pierangeli G, Montagna P. Abnormal platelet mitochondrial function in patients affected by migraine with and without aura. Cephalalgia 1994;14:21-3
60. 31P magnetic resonance spectroscopy. J Cereb Blood Flow Met 1992;12:584-92
61. Scherg M, Vajsar J, Picton TW. A source analysis of the late human auditory evoked potentials. J Cogn Neurosci 1989;1:336-55
62. Schoenen J. Clinical neurophysiology studies in headache: a review of data and pathophysiological hints. Funct Neurol 1992;7:191-204
63. Schoenen J, Maertens de Noordhout A. The role of the sympathetic nervous system in migraine and cluster headache. In: Olesen J, Edvinsson L, eds. Basic Mechanisms of Headache. Pain Research and Clinical Management, vol. 2. Amsterdam: Elsevier, 1988;393-410
64. Schoenen J, Jamart B, Delwaide PJ. Cartographie électroencéphalographique dans les migraines en périodes critique et intercritique. Rev EEG Neurophysiol Clin 1987; 17:289-99
65. Schoenen J, Maertens de Noordhout A, Timsit-Berthier M, Timsit M. Contingent Negative Variation (CNV) as a Diagnostic and Physiopathologic Tool in Headache Patients. In: Clifford Rose F, ed. Migraine: clinical and research advances. Basel: Karger, 1985;17-25
66. Schoenen J, Wang W, Albert A, Delwaide PJ. Potentiation instead of habituation characterizes visual evoked potentials in migraine patients between attacks. Eur J Neurol 1995;2:115-22
67. Schoenen J, Maertens de Noordhout A, Timsit-Berthier M, Timsit M. Contingent negative variation and efficacy of beta-blocking agents. Cephalalgia 1986;6:229-33
68. Sokolov EN. Perception and the Conditioned Reflex. Oxford: Pergamon, 1963
69. Thompson RF, Spencer WA. Habituation: a model phenomenon for the study of neuronal subtrates of behavior. Psychol Rev 1966;7:16-43
70. Thompson RF, Berry SD, Rinaldi PC, Berger TW. Habituation and orienting reflex: the dural-process theory revised. In: Kimmel HD, van Olst EH, Orlebeke JF, eds. The orienting reflex in humans. Hillsdale, NJ: Laurence Erlbaum Associates, 1979;21-60
71. Wang W, Schoenen J, Timsit-Berthier M. Cognitive functions in migraine without aura between attacks: a psychophysiological approach using the "oddball" paradigm. Neurophysiologie Clinique, 1995;25:3-11
72. Wang W, Timsit-Berthier M, Schoenen J. Intensity dependence of auditory evoked potentials in migraine: an indication of cortical potentiation and low serotonergic neurotransmission? Neurology 1996; (in press)
73. Wang W, Timsit-Berthier M, Schoenen J. Negative correlation between sensation seeking behavior and intensity dependence of auditory evoked potentials in migraine. Cephalalgia 1995;15:65
74. Welch KMA. Migraine: a biobehavioral disorder. Cephalalgia 1986;6:103-110
75. 31phosphorus NMR spectroscopy. Neurology 1989;39:538-541
76. Winter AL, Cooper R. Neurophysiological measures of the visual system in classic migraine. In: Clifford Rose C, ed. Migraine Proc 5th, Int Migraine Symp, London 1994. Basel: Karger, 1985;11-16
77. Woods RP, Iacoboni M, Mazziotta JC. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994;331:1689-92
78. Wray GH, Mijovic-Prelec D, Kosslyn SM. Visual processing in migraineurs. Brain 1994;118:25-35